Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders

Overview of attention for article published in Brain, April 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 4 news outlets
twitter: 27 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 445 Dimensions

Readers on

mendeley: 385 Mendeley
citeulike: 1 CiteULike

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 33 X posts from 27 X users, with an upper bound of 150,964 followers.

RT @EpilepsiaHRI: @FiladelfiaGene1 Rikke Moller nos recuerda la importancia de conocer si estamos ante #ganancia o #perdida de función en e…

03 Jun 2022

Reply Repost Favourite

@FiladelfiaGene1 Rikke Moller nos recuerda la importancia de conocer si estamos ante #ganancia o #perdida de función en epilepsia relacionada #SCN2A, #Epigens🧬 Una de las claves es la edad de inicio: menores de 3 meses tienden a ser ganancia👇 Link: https

03 Jun 2022

Reply Repost Favourite

RT @Brain1878: Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders https://t.co/bDu6ZZOuJH htt…

03 Jun 2018

Reply Repost Favourite

Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. - PubMed - NCBI https://t.co/St4mHMSmzx

03 May 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 29 additional X posts.